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Abstract
Mycoplasma ovipneumoniae is a globally distributed pathogen that has been associated
with pneumonia in both domestic and wild Caprinae. It is closely related to M. hyopneumo-
niae, a respiratory pathogen of swine that is associated with decreased growth rates of pigs
as well as clinical respiratory disease. In order to assess the effects of M. ovipneumoniae on
lamb performance, we generated a cohort of lambs free of M. ovipneumoniae by segrega-
tion of test negative ewes after lambing, then compared the growth and carcass quality traits
of M. ovipneumoniae-free and -colonized lambs from weaning to harvest. Some signs of
respiratory disease were observed during the feeding trial in both lamb groups, but the M.
ovipneumoniae-exposed group included more affected lambs and higher average disease
scores. At harvest, lungs of lambs in both groups showed few grossly visible lesions,
although the M. ovipneumoniae-exposed group did exhibit increased microscopic lung
lesions (P<0.05). In addition, M. ovipneumoniae exposed lambs produced lower average
daily gains (P<0.05), and lower yield grade carcasses (P<0.05) compared to those of non-
exposed lambs. The results demonstrated the feasibility of test and segregation for elimina-
tion of M. ovipneumoniae from groups of sheep and suggested that this pathogen may
impair lamb growth and productivity even in the absence of overt respiratory disease.
Introduction
The bacterium Mycoplasma ovipneumoniae was originally isolated and described from a Aus-
tralian sheep flock experiencing a high incidence of pneumonia in lambs [1]. Lesions associ-
ated with the disease included proliferative interstitial pneumonia with septal and bronchiolar
epithelial cell hyperplasia and proliferation, with additional infiltration in some cases by lym-
phocytes or neutrophils. This disease has since been observed to have a global distribution, a
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variable but generally low severity, and has been variously termed enzootic pneumonia,
chronic non-progressive pneumonia, or interstitial pneumonia [2]. In severe cases, enzootic
pneumonia may involve co-infection with multiple genetic strain types of M. ovipneumoniae
and also other bacterial respiratory pathogens, including prominently Mannheimia haemoly-
tica [3, 4]. Enzootic pneumonia has been associated with adverse effects on lamb growth and
productivity [5–9].
M. ovipneumoniae is a member of the neurolyticum/hyopneumoniae subgroup of myco-
plasmas, which also includes M. hyopneumoniae of swine, M. dispar of cattle, and M. conjuncti-
vae of sheep and goats [10, 11]. M. hyopneumoniae is recognized as an important pathogen
contributing to respiratory disease and unthriftiness in pigs [12, 13]. The combined impacts of
M. hyopneumoniae on respiratory disease and impaired growth have led to the recent develop-
ment and adoption of methods to eliminate this pathogen from large swine herds through the
use of breeding management combined with antibiotic therapy [14, 15]. If the effects of M.
ovipneumoniae on lamb growth and productivity are similar to those of M. hyopneumoniae in
swine, similar efforts at flock-level elimination of this pathogen may be merited.
M. ovipneumoniae is widespread in US sheep operations. The USDA National Animal
Health Monitoring Service included diagnostics for M. ovipneumoniae in its Sheep 2011 survey
of 450 US domestic sheep operations [16]. Evidence of M. ovipneumoniae colonization was
detected in approximately 90% of operations. M. ovipneumoniae has also recently been identi-
fied as the primary pathogen initiating severe epizootics of pneumonia in bighorn sheep [17,
18]. Further complicating the picture, M. ovipneumoniae may also be detected in the lungs of
lambs in the absence of overt clinical signs or grossly visible lesions of enzootic pneumonia [2,
19]. These sub-clinical infections may also play a role in impaired lamb growth and productiv-
ity that would not be detected in studies that rely solely on grossly visible lung lesions as a
marker for infection.
While previous studies of enzootic pneumonia have generally compared groups of lambs
that differed in the extent of grossly visible lung lesions, our approach was designed to evaluate
the effects of M. ovipneumoniae infection regardless of the extent of visible pneumonia lesions.
Therefore, the objective of this study was to determine the feasibility of producing a cohort of
lambs unexposed to M. ovipneumoniae on an infected premises in order to evaluate the effects
of M. ovipneumoniae infection or colonization of domestic lambs from weaning to harvest.
Materials and methods
Ethics statement
This study was carried out in accordance with the recommendations in the Guide for the Care
and Use of Laboratory Animals of the National Institutes of Health and in conformance with
United States Department of Agriculture animal research guidelines, under protocol #04482
approved by the Washington State University Institutional Animal Care and Use Committee
(WSU IACUC). Parts of this study were conducted at the University of Idaho Sheep Center
under that same Washington State University IACUC protocol under a memorandum of
understanding with the University of Idaho Laboratory Animal Research office.
Animals and husbandry
The study was conducted using lambs from a cross-bred production flock of approximately
100 ewes located at the University of Idaho Sheep Center. Carrier and non-carrier ewes were
identified by longitudinal testing using nasal swab samples tested by realtime polymerase
chain reactions (PCR). After lambing, lambs were supplemented with selenium and vitamin E
(0.5 ml Bo-Se, Merck Animal Health, Madison NJ) and carrier and non-carrier ewes with their
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lambs were separated and housed in non-adjacent pens to prevent nose-to-nose contact. Dur-
ing this period, the pre-weaned lambs had access to the feed available to the ewes, which con-
sisted of a 50:50 mix of rolled corn and whole barley (1 kg/ewe/day) plus long-stemmed dairy-
quality alfalfa hay (2 kg/ewe/day). At approximately 65 days of age the lambs were weaned,
weighed, and vaccinated with Clostridial CDT bacterin/toxoid. A second dose of CDT vaccine
was administered 30 d later during the feeding trial.
Microbiology
M. ovipneumoniae was detected in nasal swab and lung samples using realtime PCR. Swabs
(BBL CultureSwabEZ, Fisher Scientific, Waltham, MA) were serially inserted into both nares
of each sampled animal, replaced in the swab sheath, and maintained at 4C for up to 3 hrs
before storage at -20C until DNA extraction. At harvest, separate swabs from each principal
bronchus (left, right, tracheal) were handled and stored similarly. Swabs were eluted by vigor-
ous agitation in 400 ul of phosphate-buffered saline, centrifuged (20,000 x g, 20 min), and the
supernatant was discarded. DNA was extracted from eluate pellets using Qiagen kits (Dneasy,
Qiagen, Valencia CA). Realtime PCR testing was performed with a modification of a previ-
ously published method [20]. Modifications included 1) use of a new primer (226Fnew 5’-
GGGGTGCGCAACATTAGTTAGTTGGTAG-3’) to replace the previously described forward
primer, modified master mix to include bovine serum albumin (final concentration, 400 ng/
ml), and 3) modified thermocycling conditions including Stage 1: 50C hold for 2 minutes fol-
lowed by 95C hold for 10 minutes; optics off; Stage 2: 40 repeat cycles of denaturation (95 C,
15 seconds, optics off) and annealing/extension (66 C, 60 seconds, optics on). The results of
the modified realtime PCR were interpreted as follows: ‘detected’ if the cycle threshold score
(CT) was 36 or lower, ‘indeterminate’ for CTs between 36 and 40, and ‘not detected’ for a CT
of 40.
Feeding trial
Two experimental groups (Exposed and Unexposed) of 20 lambs each were selected from the
segregated ewe groups based on similar weaning weights and twin/single lambing types
(Table 1), moved to Washington State University and housed in separate barns 90 m apart and
that housed no other sheep or goats. Lambs from each group were allotted to lightweight and
heavyweight pens of 10 lambs each based on initial weights. Pens were 62 to 78 m2 in area. The
lambs were fed a pelleted alfalfa-barley ration for the trial, which was initially supplemented by
long stemmed hay offered ad libitum during a one week transition period. The pellet composi-
tion (per 1000 kg) was alfalfa meal 870 kg), barley (100 kg), yellow grease (20 kg), ammonium
chloride (5 kg), selenium-supplemented trace mineral salt (3.5 kg), lasalocid (1.8 kg at 12.43 g/
kg; Bovatec, Zoetis, Parsippany NJ), vitamin A premix (0.04 kg at 30 KIU/g), vitamin D premix
(0.03 kg at 8.8 MIU/kg), vitamin E-50 (0.02 kg at 500 KIU/kg), and Manganese Oxide (0.02
kg). The pelleted ration was determined to contain 16.9% crude protein, 36.9% neutral deter-
gent fiber, 26.2% acid detergent fiber, 4.8% lignin/cutin, and 1.4% acid insoluble ash/silica
(Dumas combustion method, AOAC 990.03, WSU Wildlife Habitat/Nutrition Laboratory,
Pullman WA). Lambs remained on feed until a final target weight of 60kg was attained. Lambs
were harvested in 3 groups at the WSU Meats Laboratory as they attained the target weight.
Health monitoring
Each lamb group was observed by a single scorer for 15 minute periods on each of 21 days
between 28 and 74 days on feed to detect coughing, increased nasal discharge, nose licking,
head shaking or increased respiratory rates. For each group on each observation day, the
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numbers of lambs observed with one or more of these signs, and the total number of signs
observed were tallied. Because of the segregated nature of the barn containing the group of
lambs with no exposure to M. ovipneumoniae, it was not possible to blind the observer to the
treatment group identity.
Carcass measurements
Hot carcass weights were obtained at harvest. At approximately 48 h postmortem, leg confor-
mation score, adjusted 12th rib fat thickness, quality grade and yield grade based on USDA
standards [21] were determined by an experienced lamb carcass evaluator (JB).
Pathology
After plucks were removed from the lamb carcasses, the hearts were separated and the lungs
and tracheas were removed from the kill floor, photographed dorsally and ventrally, and tissue
samples from both anterior lung lobes were removed and fixed in 10% neutral buffered forma-
lin. Gross lung photos were evaluated by a pathologist blind to the treatment group of the
lambs, and scored on a scale of 0 to 3 representing observed consolidation affecting 0,<5%,
5–10%, and>10%, respectively, of the lung surface. After fixation, lung tissues were processed
and embedded in paraffin, sectioned, and stained by hematoxyln and eosin using routine pro-
cedures at the Washington Animal Disease Diagnostic Laboratory. Slides were evaluated by a
Table 1. Demographic, growth, and carcass factors of lambs by M. ovipneumoniae exposure group prior to and
during the feeding trial and at harvest.
Factor Exposed Unexposed P-value
Pre-trial
Gender (F = ewe; M/C = wether) 8 F 12 M/C 12 F 8 M/C
Birth type (S = single; T = twin) 2 S 18 T 2 S 18 T
Birthweight; mean (SD) kg 5.94 (1.21) 6.03 (0.77) 0.781
Age at feeding trial start; mean (SD) days 67.9 (4.1) 67.4 (2.4) 0.231
Weight at feeding trial start; mean (SD) kg 29.1 (5.1) 28.5 (34) 0.621
Feeding trial
Days on feed; mean (SD) 84.5 (6.22) 81 (7.18) 0.101
Final live weight; mean (SD) kg 61.16 (5.84) 61.39 (4.02) 0.881
Average daily gain (ADG) on feed; mean (SD) kg 0.38 (0.04) 0.41 (0.05) 0.051
Respiratory disease score; mean (SD) points 9.71 (4.36) 6.23 (4.11) 0.011
Respiratory disease count; mean (SD) 7.0 (3.1) 4.7 (2.8) 0.021
Harvest
Carcass weight; mean (SD) kg 28.27 (3.02) 29.06 (2.16) 0.351
Fat thickness; mean (SD) cm 0.43 (0.09) 0.55 (0.13) 0.011
Dressing percentage mean (SD) percent 46.22 (1.79) 47.33 (1.34) 0.031
Yield grade, mean (SD) 2.09 (0.38) 2.56 (0.51) 0.031
Quality grade, mean (SD) 11.46 (1.04) 12.18 (0.81) 0.071
Leg score, mean (SD) 11.4 (0.92) 12.0 (0.87) 0.081
Lung gross lesion score; No. lambs with 0, 1, 2, 3 pts 6, 12, 1, 1 7, 10, 2, 1 0.892
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ACVP-certified veterinary pathologist (KAP) unaware of the exposure group source of the
tissues.
Results and discussion
Prior to lambing in 2016, a group of commingled ewes was serially sampled to detect M. ovip-
neumoniae colonization using nasal swabs tested by a realtime PCR assay that targets a spe-
cies-specific region of the small ribosomal subunit encoding locus. Heterogeneity of M.
ovipneumoniae detection was observed, including some ewes that tested positive on every sam-
pling date (carrier ewes) while others consistently tested negative. Our working definition of
non-carrier ewes included those whose median CT score for the realtime PCR was 40, inter-
preted as ‘not detected’ (Fig 1).
After lambing, non-carrier and carrier ewes, together with their lambs, were placed in sepa-
rate pens that did not permit nose-to-nose contact. The non-carrier ewe group included 16
ewes with 27 lambs and the carrier ewe group included 18 ewes with 30 lambs. When the
lambs reached approximately 60 days of age, nasal swabs from a convenience sample of 21
lambs in the carrier ewe pen were tested for M. ovipneumoniae and that agent was detected 7
of the lambs, indicating the onset of natural transmission of the agent; all non-carrier group
lambs tested negative for M. ovipneumoniae at that time. At weaning at approximately 65 days
of age, experimental groups of 20 lambs each were selected from the carrier and non-carrier
pens, balancing lamb body weights and twin/single lambing types across the groups (Table 1),
and moved to Washington State University, where they were housed in separate facilities sepa-
rated by 90 m and transitioned to the pelleted ration over a one week period.
All lambs on trial were weighed and tested for M. ovipneumoniae carriage at 27, 46, 61, 74,
and 88 days on feed. M. ovipneumoniae was never detected in any unexposed lamb during the
feeding period, but was detected from all exposed lambs on each sampling date after the start
of the trial. With regular observation, diverse respiratory disease signs were observed in both
groups of lambs. However, signs were observed in more lambs per observation date, and more
signs were observed per lamb in the exposed group than in the unexposed group (Table 1,
Fig 2).
As they reached the target body weight, lambs were harvested in three groups at the WSU
Meats Laboratory, including 15 lambs each after 74 and 88 days on feed. The final ten lambs,
harvested on trial day 91, included several lambs that failed to reach the target weight. While
most lambs reached 55 kg or higher body weight, two lambs in each group weighed <55 kg
(Exposed group: 47.2, 45.9 kg; non-exposed group: 51.8 and 53.6 kg). At harvest, M. ovipneu-
moniae was not detected from bronchi of any unexposed group lambs. M. ovipneumoniae was
detected in one or more bronchial swabs of all 20 exposed group lambs, including one bron-
chus of two lambs, two bronchi of one lamb, and all three bronchi of the remaining 17 lambs.
Univariate comparisons of lamb growth during the pre-feeding and -feeding periods, car-
cass traits, and gross and microscopic lung lesions are presented in Table 1. Factors that dif-
fered significantly between exposed and unexposed group lambs included average daily gains,
respiratory disease scores and counts, carcass traits including fat thickness, dressing percent-
age, and yield grade, and microscopic lung lesion scores. Interestingly, the most pronounced
group-associated differences in average daily gains occurred during the first month on feed,
when average daily gains were 0.26 ± 0.16 (mean ± SD) for exposed lambs and 0.039 ± 0.13 for
unexposed lambs (P = 0.008, 2-sample t-test), coinciding with the period when the prevalence
of M. ovipneumoniae infection increased from 33% to 100% of the exposed lamb group. Others
have also observed that the most dramatic effects of experimentally reproduced chronic non-
progressive pneumonia occur during the first 30 days after challenge [5, 6]. Analysis of
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variance was conducted using the model ADG ~ Group + Sex + Birth type + error. No signifi-
cant 2-way interactions were detected. Independent significant effects of the M. ovipneumo-
niae exposure group and the birth number (single vs twin) on average daily gain (ADG) were
detected, along with a trend for significance of lamb gender (Table 2).
Our results confirm the feasibility of producing a cohort of lambs free from M. ovipneumo-
niae exposure. In this study, unexposed lambs exhibited fewer respiratory disease signs, gained
body weight faster, tended to have improved carcass quality traits and had fewer microscopic
Fig 1. Longitudinal sampling of 34 ewes for M. ovipneumoniae. Each ewe was sampled using nasal swabs tested by reatlime PCR on 5 or 6 occasions between
November 2015 and March 2016. In each boxplot, the central heavy line represents the median value, the boxes represent the quartiles, the whiskers indicate
the largest and smallest observations within 1.5 quartiles of the box, and circles represent outlying values. The realtime PCR test is interpreted based on the CT
score, with scores below 36 interpreted as detection of M. ovipneumoniae, scores of 40 interpreted as non-detection, and scores between 36 and 40 interpreted
as indeterminate for detection.
https://doi.org/10.1371/journal.pone.0207420.g001
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lung lesions at harvest than the conventional M. ovipneumoniae exposed lambs; however, due
to the single source of animals and the small numbers of study animals, health and growth
effects need additional assessments in future studies to determine their repeatability.
The design of this trial differed from previous studies of the health and productivity effects
of chronic non-progressive pneumonia of lambs in several ways. First, our design was based
on the hypothesis that M. ovipneumoniae is a necessary component of this multi-factorial,
polymicrobial disease. While we did observe subtle increases in clinical signs of respiratory dis-
ease and microscopic evidence of lung pathology in the lambs in the exposed group in this
study, gross lesions of moderate or severe pneumonia were rare and did not differ among
groups. This is an important observation because many previous studies of the adverse health
and economic effects of chronic non-progressive pneumonia relied wholly or in part on detec-
tion of grossly visible lung lesions as the outcome variable [7–9, 22], suggesting that their find-
ings could have been confounded by effects of sub-clinical M. ovipneumoniae infections in
their ‘non-pneumonic’ controls. Secondly, the study flock where our lambs originated was not
experiencing higher than average or expected respiratory disease losses at the time of the
study, whereas some previous studies had selected flocks based on higher than expected fre-
quency of pneumonia mortality or higher than average prevalence of lung lesions at necropsy
[8, 22]. Thirdly, our method of generating the study groups ensured that the groups differed in
exposure to M. ovipneumoniae throughout the duration of the trial, not just at the end, whereas
previous trials may not have documented M. ovipneumoniae infection at all or accounted for
Fig 2. Cumulative counts of lambs exhibiting respiratory disease signs, and their cumulative respiratory signs
scores. Data plotted represent 3-date rolling averages.
https://doi.org/10.1371/journal.pone.0207420.g002
Table 2. Analysis of variance of average daily gains (ADG) in kilograms through the duration of the feeding trial.
Residual standard error: 0.043 on 36 degrees of freedom; Multiple R-squared: 0.2627, Adjusted R-squared: 0.2013; F-
statistic: 4.275 on 3 and 36 DF, p-value: 0.011.
ADG to harvest
Factor� Estimate Std. Error t value P-value
Intercept 0.452 0.023 19.39 <0.001
Group (Exposed) -0.034 0.014 -2.42 0.021
Sex (wether) 0.0198 0.014 1.42 0.164
Birth type (twin) -0.056 0.023 -2.46 0.019
�Group (Exposed) in comparison with the M. ovipneumoniae-free group; Sex (wether) in comparison with ewe
lambs; Birth type (twin) in comparison single births.
https://doi.org/10.1371/journal.pone.0207420.t002
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infections that may have been cleared by the time of harvest. Together, these differences may
have provided this study with better sensitivity to detect an effect of M. ovipneumoniae on
lamb growth and productivity compared to previous efforts.
This study has several limitations, including the relatively small lamb group sizes, and the
sourcing of all lambs from a single premises with a moderate prevalence of M. ovipneumoniae
colonized ewes. Therefore, the results may not predict results on other premises with different
geographical locations, biosecurity practices, ewe breeds, or prevalence of M. ovipneumoniae
colonization. For example, on a high prevalence operation, it may be difficult or impossible to
identify sufficient non-carrier ewes to produce a non-exposed lamb cohort of a desired size.
In conclusion, this pilot study documented the feasibility of producing a cohort of M. ovip-
neumoniae-unexposed animals through longitudinal application of a sensitive nasal swab–real-
time PCR method. We also observed improved growth and carcass quality in the M.
ovipneumoniae-unexposed lamb group, although those results require replication to confirm
their magnitude and consistency. In general, these results support the hypothesis that elimina-
tion of M. ovipneumoniae may be feasible and may be of real economic value, providing a
rationale for additional, larger scale studies.
Supporting information
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